November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE ... eluting bioresorbable scaffold for treating below-the-knee (BTK) peripheral ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

Although complications associated with peripheral vascular devices are typically minor, some infants may experience life-threatening sequelae or serious and prolonged alterations in function.

"By 2024, the market is projected to reach a staggering US$597.00bn worldwide. Among these markets, Medical Devices are expected to dominate, with a projected market volume of US$508.00bn by 2024.

Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent ...

Over 50% of these patients experience vascular access failures ... a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access ...

Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device ...

November 11, 2024—iVascular announced the initiation of OPAL, a first-in-human study of Amber, the company’s embolic liquid ...

Avinger Inc. ( (AVGR) ) has released its Q3 earnings. Here is a breakdown of the information Avinger Inc. presented to its investors. Avinger, ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.